New UBS ETFs on Xetra: Gender Equality ETF and Factor Strategy ETF on US companies

Release date: 07 Feb 2020 | Deutsche Börse Cash Market

New UBS ETFs on Xetra: Gender Equality ETF and Factor Strategy ETF on US companies

Since Friday, two new Exchange Traded Funds issued by UBS Global Asset Management are tradable on Xetra and Börse Frankfurt.

The new UBS ETF (IE) Global Gender Equality UCITS ETF (hedged to EUR) A-acc offers investors access to companies that are highly committed to sustainability and gender equality. The Solactive Equileap Global Gender Equality 100 Leaders Index comprises 100 companies worldwide that are rated particularly highly according to the 19 defined gender criteria of Equileap, an independent research organization for gender equality. Companies involved in weapons, gambling and tobacco or on the list of the Norwegian Ethics Council are excluded. The exchange rate risk against the euro is minimised.

The UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc gives investors the opportunity to invest in US companies from various sectors. A strategic multi-factor approach is chosen for the portfolio composition. The underlying MSCI USA Select Factor Mix Index is based on a combination of six factor indices and tracks the performance of long-term risk factors such as momentum, net asset value, quality, shareholder return, volatility and size.

Name

Asset class

ISIN

Ongoing charges

Distribution policy

Reference index

UBS ETF (IE) Global Gender Equality UCITS ETF (hedged to EUR) A-acc

Equity ETF

IE00BDR5H073

0.30
per cent

Distributing

Solactive Equileap Global Gender Equality 100 Leaders Index

UBS ETF (IE) MSCI USA Select Factor Mix UCITS ETF (USD) A-acc

Equity ETF

IE00BDGV0415

0.30
per cent

Distributing

MSCI USA Select Factor Mix Index

The product offering in Deutsche Börse's XTF segment currently comprises a total of 1,525 ETFs. With this selection and an average monthly trading volume of around €11 billion, Xetra is the leading trading venue for ETFs in Europe.

Further information